Abstract:Abstract Introduction Untargeted metabolomics, an analysis of the molecular layer comprising many smaller molecular weight biomolecules, has emerged as a tool to diagnose and predict outcomes early in disease courses. Existing studies of metabolic changes following burn injury focus on select targeted metabolites using animal models. This study aims to identify metabolic signatures associated with burn severity and clinical outcomes using untargeted metabolomics analysis in patients. Methods Burn patients admitted to a regional center over the span of 4 years were prospectively enrolled in this study. Patient demographics, burn injury characteristics, and blood samples were collected at set timepoints from admission until 4 weeks. Mass spectrometry (MS)-based method was used to measure untargeted metabolomics. Comparison of the MS-based measurements of select metabolites with alternate standard clinical assaying was performed to ensure concordance and reliability. A linear regression model was then used to identify metabolites associated with bun severity (TBSA < 20% and ≥ 20%). Age, gender, BMI, presence of inhalation injury, administration of propofol and supplemental nutrition were added as covariates to control for confounding effects. Results Complete metabolome datasets were collected for 58 patients from a total of 115 patients reviewed. The sample had a median TBSA of 18.3%, median age of 38.5 and 27.6% had concomitant inhalation injury. A total of 925 metabolites, including 335 lipids, 183 amino acids, 146 xenobiotics, 24 carbohydrates, and 23 peptides were analyzed. MS-based measurements compared with alternate standard clinical assaying resulted in a high level of concordance (R ~ 0.8). The first two principal components (account for 22% of total variance) show the main drivers of global metabolomics variation are time since admission and severity of injury. At admission, a significant elevation of xenobiotics, amino acids, nucleotide, and lipids related metabolites was observed among severely burned patients (TBSA ≥ 20%). Longitudinal analysis reveal that xenobiotic related metabolites are significantly elevated at admission but are depleted overtime. An abundance of select metabolites at admission showed an excellent ability to predict 30-day mortality (AUROC ~ 90%). Conclusions Patterns of metabolic alterations were associated with severe burn injury (TBSA ≥ 20%). Distinct classes of metabolic profiles change in a time dependent manner. Therefore, metabolic profiling has the potential to be used as early indicators of disease severity and progression. Applicability of Research to Practice Identifying and utilizing early indicators of disease severity and outcomes before the onset of clinical signs is crucial for burn patients. Metabolomic changes is a prime candidate for the development of these prognostic and biomarker panels.

Mechanism and Target Spot of Burn and Burn Treatment Based on Network Pharmacology

Network pharmacology approaches for research of Traditional Chinese Medicines

Molecular Mechanisms Related to Burns, Burn Wound Healing and Scarring

Burn-Related Peripheral Neuropathy: A Systematic Review

Network pharmacology and molecular docking studies on the mechanism of action of moist exposed burn ointment for treatment of diabetic foot ulcer

[Immune function evaluation and immunomodulation for severe infection following burns and trauma].

Molecular imbalance mechanism of skin and blood leucocytes in severe burn patients at different burn times

The Asynchronous Dynamic Changes and Interrelationships Between Leukocyte Composition and Inflammatory Markers and Potential Clinical Significance in the Early Stage and Sepsis Stage in Severe Burns.

Neuro-Inspired Biomimetic Microreactor for Sensory Recovery and Hair Follicle Neogenesis under Skin Burns

Topical Antimicrobials for Burn Wound Infections

[The Therapeutic Strategy for Burn Wounds].

21 Untargeted Metabolomics Analysis: A Candidate Biomarker and Prognostic Tool in Burn Injury

Burns: Classification, Pathophysiology, and Treatment: A Review

Prevention and management of burn wound sepsis

Investigation and assessment of neutrophil dysfunction early after severe burn injury

Pathophysiology of Severe Burn Injuries: New Therapeutic Opportunities From a Systems Perspective

Burn Ointment Promoted Cutaneous Wound for Burns and Scalds by Modulating the PI3K/AKT/mTOR Signaling Pathway

[Study about Target-Network of Anti-Cerebral Infarction Neuropathy Based on Theory of Neurovascular Unit and Network Pharmacology].

Burn injury: Challenges and advances in burn wound healing, infection, pain and scarring

Novel pharmacotherapy for burn wounds: what are the advancements

Burns Impair Blood-Brain Barrier And Mesenchymal Stem Cells Can Reverse The Process In Mice